Heidelberg Pharma AG annual operating income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Heidelberg Pharma AG Operating Income Growth & History (HPHA)
Heidelberg Pharma AG's operating income was −€42.1M for fiscal 2025.
View full Heidelberg Pharma AG company overviewHeidelberg Pharma AG annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | −€42.1M | −€21.4M | — |
| 2024 | 2024-11-30 | −€20.7M | €540,000 | — |
| 2023 | 2023-11-30 | −€21.2M | −€4.0M | — |
| 2022 | 2022-11-30 | −€17.2M | €8.5M | — |
| 2021 | 2021-11-30 | −€25.6M | −€7.3M | — |
| 2020 | 2020-11-30 | −€18.4M | −€8.2M | — |
| 2019 | 2019-11-30 | −€10.1M | €1.5M | — |
| 2018 | 2018-11-30 | −€11.7M | −€920,000 | — |
| 2017 | 2017-11-30 | −€10.8M | −€4.4M | — |
| 2016 | 2016-11-30 | −€6.4M | €160,000 | — |
| 2015 | 2015-11-30 | −€6.5M | −€940,000 | — |
| 2014 | 2014-11-30 | −€5.6M | −€620,000 | — |
| 2013 | 2013-11-30 | −€5.0M | €4.0M | — |
| 2012 | 2012-11-30 | −€8.9M | €4.5M | — |
| 2011 | 2011-11-30 | −€13.4M | €9.7M | — |
| 2010 | 2010-11-30 | −€23.1M | — | — |
Heidelberg Pharma AG quarterly operating income
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | €444,280 | €9.4M | — |
| Q1 2026 | 2026-02-28 | −€5.4M | €2.3M | — |
| Q4 2025 | 2025-11-30 | −€20.3M | — | — |
| Q2 2025 | 2025-05-31 | −€8.9M | — | — |
| Q1 2025 | 2025-02-28 | −€7.7M | — | — |
Heidelberg Pharma AG operating income trends
Over the last five fiscal years, Heidelberg Pharma AG's operating income decreased from −€18.4M to −€42.1M, a change of −€23.7M. The latest reported quarter, Q2 2026, shows €444,280.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
reported operating income
TickerStat standardizes operating income reported in company official filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Heidelberg Pharma AG source filings ↗Community posts
Heidelberg Pharma reports early myeloma responses and selects a development dose
Heidelberg Pharma ($HPHA) presented Phase 1 results for pamlectabart tismanitin, its experimental antibody-drug conjugate for relapsed or refractory multiple myeloma. Among 31 evaluable patients in dose cohorts five through nine, 13 respond ...
